Home Insights Due Diligence Essential in Selecting CMO Due Diligence Essential in Selecting CMO June 1, 2010 June 1, 2010 (Vol. 30, No. 11) Firms Must Look Beyond Credentials to Find the Right Partner for Their Manufacturing Needs InsightsBiomanufacturingGenetic Engineering and BiotechnologyNanoparticlesNanotechnologyTechnology and Computational Biology Also of Interest Bruker to Acquire NanoString with $392.6M Winning Bid China Upholds Key CVC CRISPR Patent Licensed through ERS Genomics Viral RNA-Based Diagnostics: Nanopore System May Outperform PCR Cloaking Device: Liu, Joung Launch $100M Nvelop Therapeutics to Advance Delivery of Genetic Cargo Bittersweet Symphony: Verve’s Pause on VERVE-101 Narrows LNP-Delivery Strategy Flipping the Script: Atomwise AI Platform Presents an Alternative to High Throughput Screening Related Media Boston and Bioprocessing: GEN Reports Live from the First Day at BPI Perfect Pitch: Genome Editing Pioneer Fyodor Urnov on Commercializing CRISPR Therapies and Epigenomic Tuning Excitement in Oakland: A Report from SynBioBeta Celebrating DNA: Matthew Cobb's Reflections on the Double Helix Breathing Oxygen Back into the Biological Conversation Global Single-Use Network Support Assurance of Supply Related Content Bruker to Acquire NanoString with $392.6M Winning Bid China Upholds Key CVC CRISPR Patent Licensed through ERS Genomics Viral RNA-Based Diagnostics: Nanopore System May Outperform PCR Cloaking Device: Liu, Joung Launch $100M Nvelop Therapeutics to Advance Delivery of Genetic Cargo